{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:08:49Z","timestamp":1759010929122},"reference-count":9,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.eimc.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,3,31]],"date-time":"2017-03-31T13:31:46Z","timestamp":1490967106000},"page":"681-682","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Hepatitis aguda fulminante por virus B durante el tratamiento del virus de la hepatitis C con antivirales de acci\u00f3n directa en paciente infectado con VIH"],"prefix":"10.1016","volume":"35","author":[{"given":"Mar\u00eda","family":"Paniagua-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"L\u00f3pez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felipe","family":"Fern\u00e1ndez-Cuenca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"R\u00edos-Villegas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2017.02.003_bib0050","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL recommendations on treatment of hepatitis C 2015","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.eimc.2017.02.003_bib0055","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.27609","article-title":"Recent US Food and Drug Administration warnings on hepatitis B reactivation with immunesuppressing and anticancer drugs: Just the tip of the iceberg?","volume":"61","author":"Di Bisceglie","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.eimc.2017.02.003_bib0060","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3851\/IMP3066","article-title":"Ledipasvir and sofosbuvir for HCV-infection in patients coinfected with HBV","volume":"21","author":"Gane","year":"2016","journal-title":"Antivir Ther"},{"key":"10.1016\/j.eimc.2017.02.003_bib0065","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/cid\/civ474","article-title":"Hepatitis B virus reactivation during successful treatment of hepatitis C virus with sofosbuvir and simeprevir","volume":"61","author":"Collins","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2017.02.003_bib0070","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/s13256-015-0630-8","article-title":"Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: A case report","volume":"9","author":"Ende","year":"2015","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.eimc.2017.02.003_bib0075","doi-asserted-by":"crossref","first-page":"710.e1","DOI":"10.1016\/j.cmi.2015.03.003","article-title":"Dominance of hepatitis C virus (HCV) is associated with lower quantitative hepatitis B surface antigen and higher serum interferon-\u03b3-induced protein 10 levels in HBV\/HCV-coinfected patients","volume":"21","author":"Wiegand","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.eimc.2017.02.003_bib0080","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/cid\/civ475","article-title":"Editorial commentary: Another call to cure hepatitis B","volume":"61","author":"Balagopal","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimc.2017.02.003_bib0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jcv.2016.02.026","article-title":"Direct-acting antiviral treatment in adults infected with hepatitis C virus: Reactivation of hepatitis B virus coinfection as a further challenge","volume":"78","author":"De Monte","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.eimc.2017.02.003_bib0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/jgh.12421","article-title":"Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: Resolved and unresolved issues","volume":"29","author":"Liu","year":"2014","journal-title":"J Gastroenterol Hepatol."}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X17300976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X17300976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,31]],"date-time":"2021-10-31T01:12:56Z","timestamp":1635642776000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X17300976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0213005X17300976"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2017.02.003","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis aguda fulminante por virus B durante el tratamiento del virus de la hepatitis C con antivirales de acci\u00f3n directa en paciente infectado con VIH","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}